[DISCLOSURE] Hansbiomed (042520) said on Aug. 29 that it has signed a contract with 2A2M Enterprise S.A.S, a Mexico-based company, to sell BellaGel, a sillicone breast implant, in the country.
The contract cost is worth 2.97 billion won (US$2.63 million), which is equivalent to 12.68 percent of the company‘s sales. The contract expires on July 29, 2019.
